Frank Mir recently announced that he was granted a therapeutic use exemption (TUE) for testosterone replacement therapy (TRT) ahead of his upcoming fight against Alistair Overeem at this weekend's (Feb. 1, 2014) UFC 169 pay-per-view (PPV) event in Newark, New Jersey.
But it won't be an easy process.
The New Jersey State Athletic Control Board (NJSACB) issued a statement regarding Mir's TUE and in doing so, revealed how the former Ultimate Fighting Championship (UFC) heavyweight champion will be heavily tested in the days leading up to -- and well after -- his fight against "The Reem."
From the official statement released to MMAmania.com:
Upon application in New Jersey, Mr. Mir was required to be seen by a board certified endocrinologist at a major medical institution for this particular exemption for this particular fight.
The detailed report from the endocrinologist and applicable medical records were reviewed by our lead MMA ringside physician Dr. Sherry Wulkan.
He has been, and will continue to be monitored via blood, hair and urine testing well prior to the event, near the event, pre bout, after the bout, and well after the competition date.
This will mark the third time Mir has received an exemption for TRT, as the jiu-jitsu ace previously obtained one for his fights against Junior dos Santos at UFC 146 and more recently against Josh Barnett at UFC 164.
Both of which he lost.
Indeed, the NJSACB isn't taking this lightly, something that's definitely music to Dana White's ears.
And it's a good thing, too, as they will likely avoid a fiasco like the one Antonio Silva went through after he decided to take an extra TRT shot a few days before his fight against Mark Hunt -- supposedly via his doctors orders -- which eventually led to his levels going through the roof.
As a result, "Bigfoot" was forced to cough up his "Fight of the Night" bonus and was suspended for nine months. Something that's unlikely to happen in Mir's case, thanks to the extra testing courtesy of the NJSACB.
For a preview of "Mir vs. Overeem" click here.